drugset / Trial / NCT03750136

Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic Syndrome

NCT03750136

Unknown 30 enrolled Medical University of Bialystok
RandomizedParallel-groupSingle-blindTreatment

Summary

The trial will test the hypothesis that hypertonic saline on top of standard diuretic treatment will help achieve adequate diuresis in patients with nephrotic syndrome.

Timeline

Start
2018-12-15
Primary completion
2023-01-01
Completion
2023-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypertonic saline Unknown 100 ml Intravenous
Background Furosemide Other / unclassified 40 mg Intravenous

Indications